Position 5-7: Finalization

Adrenal Glands

Select the specific approach and device combination to identify the exact billable procedure code.

Approach 9

High Dose Rate (HDR)

Device 7

DG1297Z Brachytherapy Adrenal Glands to None with Cesium 137 (Cs-137), High Dose Rate (HDR) Approach

Device 8

DG1298Z Brachytherapy Adrenal Glands to None with Iridium 192 (Ir-192), High Dose Rate (HDR) Approach

Device 9

DG1299Z Brachytherapy Adrenal Glands to None with Iodine 125 (I-125), High Dose Rate (HDR) Approach

Device B

DG129BZ Brachytherapy Adrenal Glands to None with Palladium 103 (Pd-103), High Dose Rate (HDR) Approach

Device C

DG129CZ Brachytherapy Adrenal Glands to None with Californium 252 (Cf-252), High Dose Rate (HDR) Approach

Device Y

DG129YZ Brachytherapy Adrenal Glands to None with Other Isotope, High Dose Rate (HDR) Approach
Approach B

Low Dose Rate (LDR)

Device 6

DG12B6Z Brachytherapy Adrenal Glands to None with Cesium 131 (Cs-131), Low Dose Rate (LDR) Approach

Device 7

DG12B7Z Brachytherapy Adrenal Glands to None with Cesium 137 (Cs-137), Low Dose Rate (LDR) Approach

Device 8

DG12B8Z Brachytherapy Adrenal Glands to None with Iridium 192 (Ir-192), Low Dose Rate (LDR) Approach

Device 9

DG12B9Z Brachytherapy Adrenal Glands to None with Iodine 125 (I-125), Low Dose Rate (LDR) Approach

Device B

DG12BB1 Brachytherapy Adrenal Glands to Unidirectional Source with Palladium 103 (Pd-103), Low Dose Rate (LDR) Approach
DG12BBZ Brachytherapy Adrenal Glands to None with Palladium 103 (Pd-103), Low Dose Rate (LDR) Approach

Device C

DG12BCZ Brachytherapy Adrenal Glands to None with Californium 252 (Cf-252), Low Dose Rate (LDR) Approach

Device Y

DG12BYZ Brachytherapy Adrenal Glands to None with Other Isotope, Low Dose Rate (LDR) Approach